Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol vs Carvedilol in Elderly HFpEF
NCT02619526Unknown
- Sponsor
- Dong-A University
- Start
- Dec 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nebivolol in heart failure with preserved ejection fraction (HFpEF) (2 arms), sponsored by Dong-A University. Primary endpoint: Ratio of transmitral E velocity to early diastolic mitral annular velocity at 12 months. Status: unknown.
02
Drugs
nebivolol
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02619526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02619526.